Jump to content

ATC code L

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by 204.112.136.242 (talk) at 17:38, 21 September 2015 (→References). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
ATC code L: Antineoplastic and immunomodulating agents
Other ATC codes

ATC code L Anfriendlytineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

== chemotherapeutic agents}}

pp

{{ }}

{{ }}

[C 

codes|L]]
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code L". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QL". WHO Collaborating Centre for Drug Statistics Methodology.
Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_L&oldid=682120109"